Cost Of Illness In Diabetic Patients with Hypertension in Inpatients at Sleman Regional Hospital

Fitriana Yuliastuti; Widarika Santi Hapsari; Nurfina Dian Kartikawati; Roshan Kumar Mahato

doi:10.30595/jhepr.v2i2.119

Authors

Fitriana Yuliastuti Universitas Muhammadiyah Magelang
Widarika Santi Hapsari Universitas Muhammadiyah Magelang
Nurfina Dian Kartikawati Universitas Muhammadiyah Magelang
Roshan Kumar Mahato Faculty of Public Health, Khon Kaen University

DOI:

https://doi.org/10.30595/jhepr.v2i2.119

Keywords:

cost of illness, diabetes, hypertension

Abstract

Abstract

In Indonesia in 2017, diabetes was one of 3 diseases that caused high mortality. Uncontrolled diabetes negatively impacts nearly every system of the human body and increases the burden of disease. The risk of developing hypertension is 1.5-2.0 times higher in diabetics compared to non-diabetics, while around a third of hypertensive sufferers have diabetes. This research was conducted to identify and calculate direct costs for diabetes and hypertension patients at Sleman District Hospital. Data collection was carried out for 3 months from medical records purposive nonrandom sampling in diabetic patients with hypertension who routinely use antidiabetic and antihypertensive drugs according to study inclusion. There were 53 patients who met the inclusion criteria consisting of 22 (41.51%) male patients and 31 (58.49%) female patients, dominated by those aged 51-60 years (32.08%) with financing using BPJS (94.34%) in class 3 (56.60%). The presence of other comorbidities during treatment, length of treatment and differences in treatment classes among patients are factors that can influence the overall costs in this study.

References

Afroz, A. et al. Cost-of-illness (COI) of type 2 diabetes mellitus (T2DM) in low and lower-middle income countries: a systematic review. BMC Health Serv. Res. 18, 972 (2018).

Thomas, R. L., Halim, S., Gurudas, S., Sivaprasad, S. & Owens, D. R. IDF Diabetes Atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018. Diabetes Res. Clin. Pract. 157, 107840 (2019).

Naseri, M. W., Esmat, H. A. & Bahee, M. D. Prevalence of hypertension (HTN) in Type-2 diabetes mellitus. Ann. Med. Surg. 78, 103758 (2022).

Hidayati, I. R., Oktaviana, A. & Pristianty, L. Cost of Illness (COI) Type 2 Diabetes Mellitus (T2DM) Outpatient BPJS on Malang City Health Center. J. Farm. DAN ILMU KEFARMASIAN Indones. 9, 1–7 (2022).

Midha, T. et al. Correlation between hypertension (HTN) and hyperglycemia among young adults in India. World J. Clin. Cases WJCC 3, 171–179 (2015).

Wang, B., Yang, Y. & Li, X. Interaction of Hypertension (HTN) and Insulin Resistance Exacerbates the Occurrence of Diabetes Mellitus (DM) in Healthy Individuals. J. Diabetes Res. 2022, 9289812 (2022).

Clua Espuny, J. L. Commentary: Diabetes and Hypertension (HTN): a Growing and Costly Epidemic. Aten. Primaria 38, 542–543 (2006).

Butt, M. D. et al. Cost of Illness (COI) Analysis of Type 2 Diabetes Mellitus (T2DM): The Findings from a Lower-Middle Income Country. Int. J. Environ. Res. Public. Health 19, 12611 (2022).

Ambianti, N. Analisis Biaya Penyakit Diabetes Melitus (DM) Sebagai Pertimbangan Perencanaan Pembiayaan Kesehatan. (Universitas Gadjah Mada, 2015).

Rosdiana, A. I., Raharjo, B. B. & Indarjo, S. Implementasi Program Pengelolaan Penyakit Kronis (Prolanis). HIGEIA J. Public Health Res. Dev. 1, 140–150 (2017).

Gunawan, S. & Rahmawati, R. Hubungan Usia, Jenis Kelamin dan Hipertensi (HTN) dengan Kejadian Diabetes Mellitus Tipe 2 (DM Tipe 2) di Puskesmas Tugu Kecamatan CiMaleggis Kota Depok Tahun 2019: (Analisis Data Sekunder Menggunakan Data Rekam Medis). ARKESMAS Arsip Kesehat. Masy. 6, 15–22 (2021).

Imelda, S. I. Faktor-Faktor yang Mempengaruhi Terjadinya Diabetes Melitus (DM) di Puskesmas Harapan Raya Tahun 2018. Sci. J. 8, 28–39 (2019).

Zhang, L., Yang, H. & Yang, P. The Correlation between Type 2 Diabetes Mellitus (T2DM) and Cardiovascular Disease (CVD) Risk Factors in the Elderly. Appl. Bionics Biomech. 2022, 4154426 (2022).

Chaudhury, A. et al. Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus (T2DM) Maleagement. Front. Endocrinol. 8, 6 (2017).

Thota, S. & Akbar, A. Insulin. in StatPearls (StatPearls Publishing, 2023).

Zhou, M.-S., Wang, A. & Yu, H. Link between insulin resistance and hypertension (HTN): What is the evidence from evolutionary biology? Diabetol. Metab. Syndr. 6, 12 (2014).

Home, P. et al. Insulin Therapy in People with Type 2 Diabetes (T2DM): Opportunities and Challenges? Diabetes Care 37, 1499–1508 (2014).

Silver, B. et al. EADSG Guidelines: Insulin Therapy in Diabetes. Diabetes Ther. Res. Treat. Educ. Diabetes Relat. Disord. 9, 449–492 (2018).

GrossMale, A. & GrossMale, E. Blood pressure (BP) control in type 2 diabetic patients. Cardiovasc. Diabetol. 16, 3 (2017).

James, P. A. et al. 2014 evidence-based guideline for the Maleagement of high blood pressure (HBP) in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311, 507–520 (2014).

Malecia, G. et al. 2013 ESH/ESC Guidelines for the Maleagement of arterial hypertension (HTN): the Task Force for the Maleagement of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 31, 1281–1357 (2013).

Shaikh, A. A Practical Approach to Hypertension (HTN) Maleagement in Diabetes. Diabetes Ther. 8, 981–989 (2017)